Richard I.G. Holt, PhD, FRCP, and Anne L. Peters, MD, and their writing team will summarize the key topics addressed by this trans-Atlantic collaboration.
Veterans and active-duty military personnel with diabetes can now receive self-management education in a simulated environment.
In 1921, the discovery of insulin transformed type 1 diabetes from a death sentence. Peter Arvan, MD, PhD, and Michael A. Weiss, MD, PhD, MBA, will explore the ramifications of this critical inflection point in medicine.
Catlin Dennis, MPH, Gretchen Piatt, PhD, MPH, Christine H. Wang, PhD, and Sarah Westen, PhD, will come together to help quantify the toll the COVID-19 pandemic has taken on diabetes patients and their families.
The data from continuous glucose monitoring devices can help patients make more informed decisions on lifestyle modifications, insulin dosing, and meal planning. Thomas W. Martens, MD, Dana Gershenoff, MS, RD, CDCES, and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, explain how.
As an early-career scientist, Nicholas J. Wareham, FMedSci, FRCP, FFPHM, MBBS, MSc, PhD, developed a strong interest in diabetes screening and was fascinated by then-emerging details of the links between risk factors and type 2 diabetes.
David G. Marrero, PhD, advocated for a social-ecological model to better understand and integrate diabetes care in a symposium focused on preserving mental health across the lifespan of living with this disease.
Maureen Monaghan, PhD, CDCES, Samantha Kleinberg, PhD, and Jennifer Raymond, MD, MCR, will offer insight into navigating the diabetes digital landscape.
An international panel of diabetes prevention researchers including Mike Sampson, MD, Kerri Lynn Knippen, PhD, MPH, RDN, LD, BC-ADM, Pilvikki Absetz, PhD, and Anne M. Wolf, MS, RDN, shared lessons learned from the implementation of type 2 diabetes prevention programs around the world during a symposium Monday.
“The road ahead for the treatment of type 2 diabetes is fresh,” said Alice Y.Y. Cheng, MD. “The future, in terms of what we will be able to offer our patients to help them meet their metabolic goals, appears to be very positive.”